Actual Medicinal Product (AMP) -
Recivit 133microgram sublingual tablets (Grunenthal Ltd)
Name Details
Current Name
Recivit 133microgram sublingual tablets
|
Start Date
14-04-2014
|
End Date
|
Summary
- Controlled Drug Category
- Schedule 2 (CD)
- Licensed Route
- Sublingual
- Availability Restrictions
- Not available
- Licensing Authority
- Medicines - MHRA/EMA
Codes
BNF |
Previous BNF
04070200
|
Start Date
29-08-2014
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
24406811000001106 |
14-04-2014 |
|
Actual Medicinal Product Pack (AMPP) Information